(VIANEWS) – Avenue Income Credit Strategies Fund (ACP), Invesco High Income Trust II (VLT), Sonic Automotive (SAH) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Avenue Income Credit Strategies Fund (ACP) | 17.96% | 2024-04-20 19:07:10 |
| Invesco High Income Trust II (VLT) | 11.18% | 2024-04-25 21:13:05 |
| Sonic Automotive (SAH) | 2.35% | 2024-04-25 01:14:07 |
| Astrazeneca (AZN) | 2.11% | 2024-04-21 03:16:03 |
A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Avenue Income Credit Strategies Fund (ACP) – Dividend Yield: 17.96%
Avenue Income Credit Strategies Fund’s last close was $6.68, 6.83% below its 52-week high of $7.17. Intraday change was -0.6%.
Avenue Income Credit Strategies Fund is a closed-ended fixed income fund launched and managed by Aberdeen Asset Managers Limited. It is co-managed by Aberdeen Standard Investments Inc. The fund invests in fixed income markets across the globe. It seeks to invest primarily in loan and debt instruments. Avenue Income Credit Strategies Fund was formed on October 12, 2010 and is domiciled in the United States.
Earnings Per Share
As for profitability, Avenue Income Credit Strategies Fund has a trailing twelve months EPS of $1.04.
PE Ratio
Avenue Income Credit Strategies Fund has a trailing twelve months price to earnings ratio of 6.42. Meaning, the purchaser of the share is investing $6.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.32%.
Moving Average
Avenue Income Credit Strategies Fund’s value is under its 50-day moving average of $6.79 and below its 200-day moving average of $6.68.
Volume
Today’s last reported volume for Avenue Income Credit Strategies Fund is 432267 which is 32.3% above its average volume of 326717.
More news about Avenue Income Credit Strategies Fund.
2. Invesco High Income Trust II (VLT) – Dividend Yield: 11.18%
Invesco High Income Trust II’s last close was $10.31, 5.15% under its 52-week high of $10.87. Intraday change was -0.35%.
Invesco High Income Trust II is a closed ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc, INVESCO Asset Management (Japan) Limited, INVESCO Asset Management Deutschland GmbH, INVESCO Asset Management Limited, Invesco Hong Kong Limited, INVESCO Senior Secured Management, Inc., and Invesco Canada Ltd. It invests in the fixed income markets. The fund seeks to invest in securities rated between BB and C by Standard and Poor's. It seeks to maintain an average duration of around three to four years for its portfolio. The fund benchmarks the performance of its portfolio against the Barclays U.S. Corporate High Yield 2% Issuer Cap Inde. It was formerly known as Invesco Van Kampen High Income Trust II. Invesco High Income Trust II was formed on April 28, 1989 and is domiciled in the United States.
Earnings Per Share
As for profitability, Invesco High Income Trust II has a trailing twelve months EPS of $0.64.
PE Ratio
Invesco High Income Trust II has a trailing twelve months price to earnings ratio of 16.11. Meaning, the purchaser of the share is investing $16.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.49%.
Moving Average
Invesco High Income Trust II’s worth is under its 50-day moving average of $10.55 and higher than its 200-day moving average of $10.29.
More news about Invesco High Income Trust II.
3. Sonic Automotive (SAH) – Dividend Yield: 2.35%
Sonic Automotive’s last close was $51.12, 15.14% below its 52-week high of $60.24. Intraday change was 0.43%.
Sonic Automotive, Inc. operates as an automotive retailer in the United States. It operates in two segments, Franchised Dealerships and EchoPark. The Franchised Dealerships segment is involved in the sale of new and used cars and light trucks, and replacement parts; provision of vehicle maintenance, manufacturer warranty repair, and paint and collision repair services; and arrangement of extended warranties, service contracts, financing, insurance, and other aftermarket products for its guests. The EchoPark segment sells used cars and light trucks; and arranges finance and insurance product sales for its guests in pre-owned vehicle specialty retail locations. Sonic Automotive, Inc. was incorporated in 1997 and is based in Charlotte, North Carolina.
Earnings Per Share
As for profitability, Sonic Automotive has a trailing twelve months EPS of $4.97.
PE Ratio
Sonic Automotive has a trailing twelve months price to earnings ratio of 10.29. Meaning, the purchaser of the share is investing $10.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.94%.
Moving Average
Sonic Automotive’s worth is under its 50-day moving average of $52.36 and under its 200-day moving average of $51.35.
Previous days news about Sonic Automotive
- Sonic automotive (sah) reports Q1 earnings: what key metrics have to say. According to Zacks on Thursday, 25 April, "For the quarter ended March 2024, Sonic Automotive (SAH Quick QuoteSAH – Free Report) reported revenue of $3.38 billion, down 3.1% over the same period last year. ", "Here is how Sonic Automotive performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
More news about Sonic Automotive.
4. Astrazeneca (AZN) – Dividend Yield: 2.11%
Astrazeneca’s last close was $75.03, 2% under its 52-week high of $76.56. Intraday change was -0.75%.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Earnings Per Share
As for profitability, Astrazeneca has a trailing twelve months EPS of $1.9.
PE Ratio
Astrazeneca has a trailing twelve months price to earnings ratio of 36.28. Meaning, the purchaser of the share is investing $36.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.64%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.3%, now sitting on 45.81B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Astrazeneca’s stock is considered to be oversold (<=20).
Volatility
Astrazeneca’s last week, last month’s, and last quarter’s current intraday variation average was 1.27%, 0.36%, and 0.95%.
Astrazeneca’s highest amplitude of average volatility was 1.27% (last week), 0.81% (last month), and 0.95% (last quarter).
Moving Average
Astrazeneca’s value is higher than its 50-day moving average of $66.12 and higher than its 200-day moving average of $66.62.
Previous days news about Astrazeneca
- Astrazeneca (azn) reports Q1 earnings: what key metrics have to say. According to Zacks on Thursday, 25 April, "For the quarter ended March 2024, Astrazeneca (AZN Quick QuoteAZN – Free Report) reported revenue of $12.68 billion, up 16.6% over the same period last year. ", "Here is how Astrazeneca performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
More news about Astrazeneca.
